SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001999371-24-000886
Filing Date
2024-01-26
Accepted
2024-01-26 09:26:26
Documents
15
Period of Report
2024-01-26
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT rain-8k_012624.htm   iXBRL 8-K 46153
2 CONTINGENT VALUE RIGHTS AGREEMENT ex2-2.htm EX-2.2 201386
3 FIFTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF RAIN ONCOLOGY INC. ex3-1.htm EX-3.1 8789
4 AMENDED AND RESTATED BYLAWS OF RAIN ONCOLOGY INC. ex3-2.htm EX-3.2 82635
  Complete submission text file 0001999371-24-000886.txt   592560

Data Files

Seq Description Document Type Size
5 XBRL LABEL FILE rain-20240126_lab.xml EX-101.LAB 34916
6 XBRL PRESENTATION FILE rain-20240126_pre.xml EX-101.PRE 22797
7 XBRL SCHEMA FILE rain-20240126.xsd EX-101.SCH 3027
9 EXTRACTED XBRL INSTANCE DOCUMENT rain-8k_012624_htm.xml XML 3657
Mailing Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560
Business Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560 (510) 953-5559
Rain Oncology Inc. (Filer) CIK: 0001724979 (see all company filings)

IRS No.: 821130967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40356 | Film No.: 24564580
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)